CytRx Corp.
(Other OTC/NBB : CYTR)

( )
CYTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.39%15.361.8%$167.34m
VRXValeant Pharmaceuticals International, Inc.
0.94%21.5014.1%$126.51m
GWPHGW Pharmaceuticals PLC Sponsored ADR
3.02%158.846.2%$83.47m
PRGOPerrigo Co. Plc
-0.74%45.816.8%$69.56m
SAGESAGE Therapeutics, Inc.
0.60%162.008.6%$61.94m
JAZZJazz Pharmaceuticals Plc
2.62%134.832.3%$54.72m
HZNPHorizon Pharma plc
0.60%27.006.7%$46.88m
UTHRUnited Therapeutics Corporation
2.33%81.3714.3%$44.61m
PTLAPortola Pharmaceuticals, Inc.
0.95%30.707.5%$43.39m
ICLRICON Plc
1.32%157.174.1%$40.19m
ICPTIntercept Pharmaceuticals, Inc.
-0.99%64.0017.2%$38.64m
CTLTCatalent Inc
1.10%55.882.4%$35.42m
MDCOMedicines Company
3.78%32.7120.3%$33.51m
AERIAerie Pharmaceuticals, Inc.
-5.62%23.196.8%$25.01m
PCRXPacira Pharmaceuticals, Inc.
-1.85%38.2210.5%$24.00m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.